Literature DB >> 27410913

CIPROFLOXACIN RESISTANCE PATTERN AMONG BACTERIA ISOLATED FROM PATIENTS WITH COMMUNITY-ACQUIRED URINARY TRACT INFECTION.

Ana Carolina Costa Reis1, Susana Regia da Silva Santos1, Siane Campos de Souza1,2, Milena Góes Saldanha2, Thassila Nogueira Pitanga3, Ricardo Riccio Oliveira3.   

Abstract

OBJECTIVE: To identify the main bacterial species associated with community-acquired urinary tract infection (UTI) and to assess the pattern of ciprofloxacin susceptibility among bacteria isolated from urine cultures.
METHODS: We conducted a retrospective study in all the patients with community-acquired UTI seen in Santa Helena Laboratory, Camaçari, Bahia, Brazil during five years (2010-2014). All individuals who had a positive urine culture result were included in this study.
RESULTS: A total of 1,641 individuals met the inclusion criteria. Despite the fact that participants were female, we observed a higher rate of resistance to ciprofloxacin in males. The most frequent pathogens identified in urine samples were Escherichia coli, Klebsiella pneumoniae and Staphylococcus saprophyticus. Antimicrobial resistance has been observed mainly for ampicillin, sulfamethoxazole + trimethoprim and ciprofloxacin. Moreover, E. coli has shown the highest rate of ciprofloxacin resistance, reaching 36% of ciprofloxacin resistant strains in 2014.
CONCLUSION: The rate of bacterial resistance to ciprofloxacin observed in the studied population is much higher than expected, prompting the need for rational use of this antibiotic, especially in infections caused by E. coli. Prevention of bacterial resistance can be performed through control measures to limit the spread of resistant microorganisms and a rational use of antimicrobial policy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27410913      PMCID: PMC4964322          DOI: 10.1590/S1678-9946201658053

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  29 in total

Review 1.  Constructions of masculinity and their influence on men's well-being: a theory of gender and health.

Authors:  W H Courtenay
Journal:  Soc Sci Med       Date:  2000-05       Impact factor: 4.634

2.  Association of fluoroquinolone resistance, virulence genes, and IncF plasmids with extended-spectrum-β-lactamase-producing Escherichia coli sequence type 131 (ST131) and ST405 clonal groups.

Authors:  Yasufumi Matsumura; Masaki Yamamoto; Miki Nagao; Yutaka Ito; Shunji Takakura; Satoshi Ichiyama
Journal:  Antimicrob Agents Chemother       Date:  2013-07-15       Impact factor: 5.191

3.  Relentless increase of resistance to fluoroquinolones and expanded-spectrum cephalosporins in Escherichia coli: 20 years of surveillance in resource-limited settings from Latin America.

Authors:  A Bartoloni; L Pallecchi; E Riccobono; A Mantella; D Magnelli; T Di Maggio; A L Villagran; Y Lara; C Saavedra; M Strohmeyer; F Bartalesi; C Trigoso; G M Rossolini
Journal:  Clin Microbiol Infect       Date:  2012-03-13       Impact factor: 8.067

4.  Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli.

Authors:  James R Johnson; Brian Johnston; Michael A Kuskowski; Evgeni V Sokurenko; Veronika Tchesnokova
Journal:  Antimicrob Agents Chemother       Date:  2015-05-18       Impact factor: 5.191

Review 5.  The quinolones: past, present, and future.

Authors:  Vincent T Andriole
Journal:  Clin Infect Dis       Date:  2005-07-15       Impact factor: 9.079

6.  [Prevalence and bacterial susceptibility of community acquired urinary tract infection in University Hospital of Brasília, 2001 to 2005].

Authors:  Marcelle Cristina da Silva Pires; Karla de Sousa Frota; Paulo de Oliveira Martins Junior; Amabel Fernandes Correia; Juan José Cortez-Escalante; Celeste Aída Silveira
Journal:  Rev Soc Bras Med Trop       Date:  2007 Nov-Dec       Impact factor: 1.581

7.  Prevalence of multidrug resistant uropathogenic bacteria in pediatric patients of a tertiary care hospital in eastern India.

Authors:  Monali P Mishra; Rachita Sarangi; Rabindra N Padhy
Journal:  J Infect Public Health       Date:  2015-11-23       Impact factor: 3.718

Review 8.  Urinary tract infections.

Authors:  Dimitri M Drekonja; James R Johnson
Journal:  Prim Care       Date:  2008-06       Impact factor: 2.907

Review 9.  Declining susceptibilities of gram-negative bacteria to the fluoroquinolones: effects on pharmacokinetics, pharmacodynamics, and clinical outcomes.

Authors:  Matthew J Labreche; Christopher R Frei
Journal:  Am J Health Syst Pharm       Date:  2012-11-01       Impact factor: 2.637

Review 10.  Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies.

Authors:  Oyebola Fasugba; Anne Gardner; Brett G Mitchell; George Mnatzaganian
Journal:  BMC Infect Dis       Date:  2015-11-25       Impact factor: 3.090

View more
  6 in total

1.  Pse-T2, an Antimicrobial Peptide with High-Level, Broad-Spectrum Antimicrobial Potency and Skin Biocompatibility against Multidrug-Resistant Pseudomonas aeruginosa Infection.

Authors:  Hee Kyoung Kang; Chang Ho Seo; Tudor Luchian; Yoonkyung Park
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

2.  Vitamin D Pretreatment Attenuates Ciprofloxacin-Induced Antibacterial Activity.

Authors:  Majed M Masadeh; Karem H Alzoubi; Bashar M Al-Taani; Majd M Masadeh; Zainah O Aburashed; Nasr Alrabadi
Journal:  Clin Pharmacol       Date:  2020-10-12

3.  Interplay of the Quality of Ciprofloxacin and Antibiotic Resistance in Developing Countries.

Authors:  Deepali Sharma; Rahul P Patel; Syed Tabish R Zaidi; Md Moklesur Rahman Sarker; Qi Ying Lean; Long C Ming
Journal:  Front Pharmacol       Date:  2017-08-21       Impact factor: 5.810

4.  Microbiology and Drug Resistance of Pathogens in Patients Hospitalized at the Nephrology Department in the South of Poland.

Authors:  Mikołaj Michno; Antoni Sydor; Marta Wałaszek; Władysław Sułowicz
Journal:  Pol J Microbiol       Date:  2018

Review 5.  Different Nanotechnology Approaches for Ciprofloxacin Delivery Against Multidrug-Resistant Microbes.

Authors:  Ashagrachew Tewabe Yayehrad; Gebremariam Birhanu Wondie; Tesfa Marew
Journal:  Infect Drug Resist       Date:  2022-02-05       Impact factor: 4.003

Review 6.  Urinary tract infection in pediatrics: an overview.

Authors:  Ana Cristina Simões E Silva; Eduardo A Oliveira; Robert H Mak
Journal:  J Pediatr (Rio J)       Date:  2019-11-26       Impact factor: 2.990

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.